Holen Sie sich die Stockscreener-App
10.22
3.11%
0.348
Schlusskurs vom Vortag:
$9.87
Offen:
$9.73
24-Stunden-Volumen:
1.14M
Relative Volume:
0.91
Marktkapitalisierung:
$1.59B
Einnahmen:
$363.55M
Nettoeinkommen (Verlust:
$-78.68M
KGV:
-20.44
EPS:
-0.5
Netto-Cashflow:
$50.74M
1W Leistung:
+0.27%
1M Leistung:
-15.05%
6M Leistung:
-10.49%
1J Leistung:
-39.96%
1-Tages-Spanne:
$9.73
$10.31
1-Wochen-Bereich:
$9.53
$10.31
52-Wochen-Spanne:
$9.41
$19.18
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Vergleichen Sie CERT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
10.21 | 1.59B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
227.16 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.01 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.45 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.60 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.15 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Checking Back In On Certara: Unattractive Valuation (NASDAQ:CERT) - Seeking Alpha
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities - The Manila Times
Certara unveils advanced drug development simulator - Investing.com
Revolutionary AI Update: How Certara's New Simcyp Platform is Transforming Drug Development - Stock Titan
Proficio Capital Partners LLC Buys Shares of 13,856 Certara, Inc. (NASDAQ:CERT) - Defense World
Why Certara, Inc. (NASDAQ:CERT) Could Be Worth Watching - simplywall.st
At US$9.91, Is Certara, Inc. (NASDAQ:CERT) Worth Looking At Closely? - Yahoo Finance
Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 - MSN
Certara Inc.: Is The Biosimulation & Software Growth Here To Stay? - Smartkarma
Commit To Buy Certara At $7.50, Earn 14.3% Annualized Using Options - Nasdaq
Raymond James Financial Inc. Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Receives $15.83 Consensus Price Target from Brokerages - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Purchased by HighTower Advisors LLC - Defense World
Avantax Advisory Services Inc. Sells 17,660 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Charles Schwab Investment Management Inc. Grows Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
PNC Financial Services Group Inc. Raises Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Amundi Raises Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Atria Investments Inc Reduces Position in Certara, Inc. (NASDAQ:CERT) - Defense World
US Bancorp DE Has $101,000 Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
(CERT) Technical Data - news.stocktradersdaily.com
Proficio Capital Partners LLC Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges By Investing.com - Investing.com South Africa
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges - Investing.com Australia
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation - Investing.com India
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation By Investing.com - Investing.com South Africa
Certara Inc (NASDAQ: CERT) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
Bank of New York Mellon Corp Purchases 1,253,385 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
23,568 Shares in Certara, Inc. (NASDAQ:CERT) Acquired by Private Advisor Group LLC - Defense World
Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - citybiz
Certara announces leadership change in drug development By Investing.com - Investing.com South Africa
Certara announces leadership change in drug development - Investing.com India
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 05:07 pm EST - Marketscreener.com
Certara Announces Leadership Change with Dr. Smith’s Departure - TipRanks
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:16 pm EST - Marketscreener.com
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:15 pm EST - Marketscreener.com
Can This Former IQVIA Executive Transform Certara's Drug Development Approach? - StockTitan
Principal Financial Group Inc. Has $5.66 Million Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Objective long/short (CERT) Report - Stock Traders Daily
Q2 Earnings Estimate for Certara Issued By William Blair - Defense World
Certara (NASDAQ:CERT) Price Target Raised to $13.00 - Defense World
Q1 Earnings Estimate for Certara Issued By Leerink Partnrs - Defense World
Rhumbline Advisers Has $2.96 Million Stock Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Brokerages Set Certara, Inc. (NASDAQ:CERT) Price Target at $15.42 - Defense World
KeyBanc maintains Overweight rating on Certara shares with $15 target - Investing.com India
KeyBanc maintains Overweight rating on Certara shares with $15 target By Investing.com - Investing.com South Africa
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Certara Inc-Aktie (CERT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS |
Oct 04 '24 |
Option Exercise |
0.00 |
7,151 |
0 |
57,242 |
0.20%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):